Cleaved-Cathepsin D LC (G65) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Cleaved-Cathepsin D LC (G65) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCleaved-Cathepsin D LC (G65)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, monkey
Isotypen/a
Formatimmunogen affinity purified
Size0.03 mL, 0.1 mL, 0.2 mL
Concentration1 mg/ml
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Cleaved-Cathepsin D LC (G65) Polyclonal Antibody detects endogenous levels of fragment of activated Cathepsin D LC protein resulting from cleavage adjacent to G65. CTSD encodes a member of the A1 family of peptidases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the cathepsin D light and heavy chains, which heterodimerize to form the mature enzyme. Cathepsin D exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors. Mutations in CTSD play a causal role in neuronal ceroid lipofuscinosis-10 and may be involved in the pathogenesis of several other diseases, including breast cancer and
ImmunogenImmunogen: Synthesized peptide derived from the internal region of human Cathepsin D LC at AA range: 20-100
Other Names[Rabbit Cleaved-Cathepsin D LC (G65); CPSD; Cathepsin D]
Gene, Accession #[CTSD], Gene ID: 1509, NCBI: NP_001900.1, UniProt: P07339
Catalog #MBS9700803
Price$130, $220, $325
Order / More InfoCleaved-Cathepsin D LC (G65) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.